EUVIMEDEUVIMED entdecken
Crossref

Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia

Yueshuang Lu, Susanne Grub, Duan Li, Isabell Haußmann, Natalia Prodan, Madhuri S. Salker, Daniel Sauter

Placenta · 2026-09 · 183 · e237

DOI: 10.1016/j.placenta.2026.08.167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2026-09. Verfasst von Yueshuang Lu und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lu, Y., Grub, S., Li, D., Haußmann, I., Prodan, N., Salker, M. S., & Sauter, D. (2026). Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia. Placenta, 183, e237. https://doi.org/10.1016/j.placenta.2026.08.167

Vancouver

Lu Y, Grub S, Li D, Haußmann I, Prodan N, Salker MS, et al. Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia. Placenta. 2026;183:e237. doi:10.1016/j.placenta.2026.08.167

BibTeX
@article{Lu2026,
  author = {Lu, Yueshuang and Grub, Susanne and Li, Duan and Haußmann, Isabell and Prodan, Natalia and Salker, Madhuri S. and Sauter, Daniel},
  title = {Antiviral signaling at the maternal-fetal interface disrupts trophoblast fusion in preeclampsia},
  journal = {Placenta},
  year = {2026},
  volume = {183},
  pages = {e237},
  doi = {10.1016/j.placenta.2026.08.167}
}
Kostenlos starten →